Both are daily semaglutide tablets, but the Wegovy pill is a 25 mg dose licensed for weight loss, and Rybelsus is up to 14 mg and licensed for type 2 diabetes
pilot human infusions well tolerated Learn More TB-500 Overview TB-500 Overview Mechanisms: Binds actin to enhance cytoskeletal remodeling and cell migrationcritical for tissue repair Learn More Primary Uses: Muscle tears, tendon/ligament injuries, cardiac protection Learn More Administration: Subcutaneous or intramuscular injections (not orally bioavailable) Safety Highlights: Low acute toxicity in animal models
Infection (e.g, deep neck space infection)
The same vial reconstituted with 1.5 mL produces 20 mg/mL
For weight management, specific criteria apply as outlined in relevant NICE technology appraisals (such as TA875 for semaglutide 2.4mg), generally requiring a BMI 35 kg/m (or 30 kg/m with weight-related comorbidities), with lower thresholds (typically 2.5 kg/m lower) for people from certain ethnic groups, and treatment within specialist weight management services
References Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI